GSGopalakrishnan Sundaram

Gopalakrishnan Sundaram

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gopalakrishnan Sundaram has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modulation of Superoxide Dismutase 2 Antioxidant Gene Expression by Adjunctive Liquorice Therapy in Periodontitis: A Pilot Randomized Controlled Trial

    by Akshatha Anand, S Gopalakrishnan, Uma Sudhakar, Manisha Manoj

    Introduction: Liquorice (Glycyrrhiza glabra) possesses diverse pharmacological properties, including antimicrobial, anti-inflammatory, antioxidant, hepatoprotective and neuroprotective effects. Superoxide Dismutase 2(SOD2), a key antioxidant enzyme, plays an important role in protecting tissues against oxidative stress and has been extensively studied in periodontitis, where oxidative stress contributes to disease progression. Objective: To assess the efficacy of liquorice as an adjunct to Scaling and Root Planing (SRP) Clinical parameters and Superoxide Dismutase 2(SOD2) levels in periodontitis patients were assessed Methodology: This randomized controlled clinical trial included 40 patients who were randomly allocated into two groups by the coin-toss method: Group 1 (control) and Group 2 (test). All patients received SRP in Group 1 and Group 2 received SRP and liquorice tablet. Clinical parameters like PPD, CAL and GCF samples (SOD2 gene expression) were evaluated at base line and 2 weeks after SRP. Results: Statistically significant improvements in clinical and biochemical parameters were observed in both Groups over time. Conclusion: Adjunctive systemic liquorice therapy may be used as an effective adjunct to SRP for treating periodontitis.

  • Open Access

    Potential of nutraceutical fucoidan against periodontal pathogens: a novel molecular docking study

    by B Bhuvaneswari, S Gopalakrishnan, U Arunmozhi, Snophia Rani Rajamani, Juala Catherine, Raghunathan Jagannathan, Thodur Madapusi Balaji

    Introduction: Fucoidan from seaweed has gained significant attention due to its diverse therapeutic properties. Its antibacterial potential in periodontitis needs exploration. Objective: This paper aims to explore the suitability of fucoidan to treat periodontitis by molecular docking methods. Methods: Molecular docking of fucoidan was done with targets from Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, and Aggregatibacter actinomycetemcomitans. Binding energy, inhibition constant, number of hydrogen bonds, aminoacid residues involved in H-Bond were identified. Control docking was done with chlorhexidine and compared. Results: Docking of Porphyromonas gingivalis enzyme, gingipain K (Kgp) with fucoidan had an inhibition constant of -6.83, ODP from T. denticola with fucoidan had binding energy of -4.52, anti-CRISPR protein AcrIF9 with fucoidan had a binding energy of 4.81 and Tannerella forsythia potempin E with Fucoidan had a binding energy of -3.09 all expresssed as kcal/mol. Respective inhibition constants were 67.3 µM, 485.11µM, 295.72 µM and 5.47 mM. All binding energies ranged from -3 to -6 range suitable for inhibition of their targets. Conclusion: Inhibition constant for targets from T. denticola and A. actinomycetemcomitans had highest values indicating that fucoidan inhibits T. denticola and A. actinomycetemcomitans more significantly than P. gingivalis and T. forsythia.

  • Open Access

    A systematic review on marine-derived fucoidan as a nutritional therapeutic in periodontal disease

    by B Bhuvaneswari, S Gopalakrishnan, U Arunmozhi, Sanketh Kethi Reddy, Hodur Madapusi Balaji

    Introduction: Fucoidan is a naturally occurring sulfated polysaccharide derived from brown seaweeds such as Fucus vesiculosus, Laminaria japonica, and Undaria pinnatifida. As a nutritive agent, fucoidan modulates tsystemic health through its bioactive components that influence metabolic, immune, and cellular functions. Its anti-inflammatory properties have a promising role in mitigating chronic low-grade inflammation, which underlies many systemic and oral diseases. Fucoidan is recently reported to possess significant antibacterial activity and the evidence regarding its use for periodontal diseases is scattered. Objective: Critical evaluation of the efficacy of fucoidan on periodontal pathogens using the existing evidence. Methods: Literature search was done on PubMed, Cochrane, Scopus, etc, according to PRISMA guidelines. Relevant articles were collected and evidence was tabulated. Results: The collected evidence indicated that fucoidan shows multifaceted therapeutic potential regarding periodontal diseases through multiple mechanisms like modulation of microbial virulence, reduction of inflammation, and boosting host–pathogen balance. Conclusion: Fucoidan exhibited promising antimicrobial, antibiofilm, and anti-inflammatory properties against periodontal pathogens.

  • Open Access

    Effect of Non-Surgical Periodontal Therapy on Systemic Inflammatory Markers, Glycemic Status and Levels of Proteinuria in Type 2 Diabetic and Non-Diabetic Patients With Chronic Periodontitis

    by S Gopalakrishnan Sundaram, T Ramakrishnan, Sneha G. Krishnan, Keerthi V. Narayan, Siva Shankar, G Kanimozhi, Siv Sankar P

    Aims and objectives: The present study aimed to evaluate the effect of non-surgical periodontal therapy (NSPT) on systemic inflammatory markers, glycemic status, and levels of proteinuria in Type 2 diabetic and non-diabetic individuals with chronic periodontitis. Methodology: A total of 120 patients, categorized into three groups of 40 each, were included in this randomized observational study. Group 1 comprised patients with chronic periodontitis; Group 2 had chronic periodontitis with controlled diabetes; and Group 3 represented patients with chronic periodontitis with uncontrolled diabetes based on fasting blood sugar (FBS) and glycated hemoglobin (HbA1c) levels. Periodontal clinical parameters like plaque index, gingival index, bleeding on probing, pocket depth, and clinical attachment levels were evaluated. Blood samples and urine samples were collected and assessed for the levels of FBS, HbA1c, total protein, albumin, globulin, and proteinuria. All parameters recorded at baseline and three months after non-surgical periodontal therapy were analyzed for statistical significance at p <.05 using SPSS Inc. Released 2007. SPSS for Windows, Version 16.0. Chicago, SPSS Inc. Results: A significant reduction in the periodontal clinical parameters within the groups, except for the clinical attachment level in Group 1 patients (p = 0.05), was observed. Glycemic status revealed a significant reduction after non-surgical periodontal therapy (p < 0.001), and on intragroup comparison, the total protein, albumin, globulin, and microprotein blood and urine levels showed significance among the evaluated groups (p < 0.001). Conclusion: Non-surgical periodontal treatment can effectively improve the periodontal and circulating inflammatory status. Results of our study showed improved glycemic control and a reduction in systemic inflammatory markers and proteinuria after performing non-surgical periodontal treatment in patients with type 2 diabetes.


  • Open Access

    Effects of Non-surgical Periodontal Therapy on Saliva and Gingival Crevicular Fluid Levels of Chemerin in Periodontitis Subjects With and Without Type 2 Diabetes Mellitus

    by Gomathi Gd, Gopalakrishnan S, Uma Sudhakar, Anusha Raghavan, Keerthi V. Narayan

    Evidence had shown a bi-directional link between diabetes mellitus and periodontitis. Chemerin, an adipose tissue-specific adipokine plays a significant role in adipocyte initiation and differentiation that directly influences glucose metabolism, lipid metabolism, and inflammatory mediators. Non-surgical periodontal therapy (NSPT) for patients with periodontitis and diabetes mellitus improves the periodontal condition and regulates glycemic level. To assess the impact of chemerin on periodontal disease and diabetes mellitus pathogenesis and to analyze the impact of NSPT on saliva and gingival crevicular fluid (GCF) chemerin levels in patients with periodontitis with and without type 2 diabetes mellitus (T2DM). A total of 60 patients were divided into four groups: Group I: Systemically and periodontally healthy subjects (n=15), Group II: Systemically healthy subjects with periodontitis (n=15), Group III: Subjects with periodontitis and T2DM (n=15), Group IV: Periodontally healthy subjects with T2DM (n=15). Indices and parameters like plaque index (PI), gingival index (GI), periodontal probing depth (PPD), and clinical attachment level (CAL) were assessed at baseline in all four groups and six weeks after NSPT in Group II and Group III. A glycated hemoglobin (HbA1c) test was taken to assess the patient's blood glucose level. Fasting blood sugar (FBS) level was taken at baseline in all the groups and six weeks after NSPT in Group II and Group III subjects. Saliva and GCF chemerin levels were assessed at baseline in all four groups and six weeks after NSPT in Group II and Group III subjects. A statistically significant difference was observed in comparing chemerin levels at baseline with all four groups (p < 0.001). After NSPT, there was a reduction in clinical parameters, FBS, and chemerin levels in Group II and Group III. A positive correlation was observed between salivary chemerin and FBS in Group II, GCF chemerin, PI, and FBS in Group II, and PPD and FBS in Group III. A negative correlation was observed between salivary chemerin and all parameters in Group II and between salivary chemerin and GCF chemerin in Group III. Based on the observed relationship between chemerin and the parameters, their utility as a dual biomarker for diagnosis and prognosis in periodontal disease seems promising. However, further studies with a larger sample size on the role of chemerin in health and various states of diseases are required to substantiate the result of the study.


  • Open Access

    Effect of piper extract mouthwash as postprocedural rinse on levels of Porphyromonas gingivalis in periodontitis patients

    by Gopalakrishnan Sundaram, Ramakrishnan Theagarajan, Gomathi Dhakshina Murthy, Gopalakrishnan Kanimozhi

    Background: Dental biofilm plays a crucial role in periodontal disease development. Mouth rinse is used to enhance oral hygiene after scaling and root planning (SRP). The aim of the study was to evaluate the clinical and microbiological effectiveness of a piper extract mouthwash against Chlorhexidine (CHX) in periodontitis patients. Materials and Methods: Sixty patients with Stage II periodontitis participated in this study and were randomly divided into two groups (Group I – Stage II Grade A periodontitis patients were provided with prepared piper extract mouthwash and Group II – Stage II Grade A periodontitis patients were provided with 0.2% CHX). Plaque index, gingival index, sulcus bleeding index, probing pocket depth, and clinical attachment level were recorded at baseline and 30 days after SRP. Subgingival plaque samples were taken for microbial examination (colony-forming unit), quantification of Porphyromonas gingivalis using the real-time polymerase chain reaction at baseline, and 30 days after SRP. Results: Intragroup comparison for the clinical parameters showed statistically significant reduction in both the groups (P < 0.0001). Intergroup comparison for clinical parameters, there was no statistical significance seen after 30 days. Intragroup comparison for microbial analysis showed significant reduction in both the groups after 30 days (P < 0.0001). On intergroup comparison for microbial analysis, both the groups showed reduction after 30 days without significance. Conclusion: Piper extract mouthwash (Group I) showed similar antimicrobial activity against P. gingivalis when compared to 0.2% CHX mouthwash (Group II) that could be used as a substitute to CHX.


  • Open Access

    Periodontal link in forensic research – An overview

    by S Gopalakrishnan, Gomathi G D, Vivekanandan U, M Sharmila

    Periodontal link in forensic research – An overview-IDJSR-Print ISSN No:-2394-708X Online ISSN No:-2278-3784Article DOI No:-10.18231/j.idjsr.2019.021,International Dental Journal of Student Research-IP Innovative Publication Pvt Limited, Medical Journals Publication, Open Access Journals, Print Journals,Indian Jour


  • Open Access

    Immediate implant– An esthetic rescue- Case series

    by S. Gopalakrishnan, Gomathi G.D, G. Kanimozhi, W R. Gnanasagar

    Immediate implant– An esthetic rescue- Case series-APRD-Print ISSN No:-2581-4796 Online ISSN No:-2581-480XArticle DOI No:-10.18231/j.aprd.2019.019,IP Annals of Prosthodontics and Restorative Dentistry-IP Innovative Publication Pvt Limited, Medical Journals Publication, Open Access Journals, Print Journals,Indian Jo


  • Open Access

    Smart phone – A silent killer to oral health

    by S. Gopalakrishnan, G D Gomathi, G Kanimozhi, Gnanasagar

    Smart phone – A silent killer to oral health-IJPI-Print ISSN No:-2581-9836 Online ISSN No:-2457-0087Article DOI No:-10.18231/j.ijpi.2019.016,IP International Journal of Periodontology and Implantology-IP Innovative Publication Pvt Limited, Medical Journals Publication, Open Access Journals, Print Journals,Indian Jo

  • Open Access

    Fenugreek, diabetes, and periodontal disease: A cross-link of sorts!

    by Gopalakrishnan Sundaram, Theyagarajan Ramakrishnan, Harinath Parthasarathy, Manoj Raja, Samuel Raj

    Aims: The aim of this study was to observe the sequelae of fenugreek adjunctive to nonsurgical periodontal therapy and its comparison to a group treated with scaling and root planing (SRP) and metformin alone by assessing their respective effects on periodontal parameters, glycemic status, and serum lipid levels. Materials and Methods: The study comprised eighty patients who were further divided into two groups. Each group consisted of 40 patients. Group 1 consisted of uncontrolled noninsulin-dependent diabetes mellitus (NIDDM) patients with chronic generalized periodontitis, who received SRP and treatment with metformin. Group 2 consisted of uncontrolled NIDDM with chronic generalized periodontitis, who received SRP and metformin plus fenugreek powder. Periodontal parameters such as gingival index, plaque index, bleeding on probing, pocket depth, and clinical attachment levels were evaluated before treatment and 1 month after nonsurgical periodontal therapy. The values of low-density lipoprotein (LDL), triglycerides, total cholesterol (TC), and glycosylated hemoglobin (HbA1c) were assessed by collecting the blood samples before treatment and 1 month after treatment. Results: There was a statistically significant change in all the parameters seen clinically in both the groups. The glycemic status also showed a statistically significant reduction for fasting blood sugar (P < 0.001) on intragroup comparison. Intragroup comparison shows a statistically significant reduction (P < 0.001) for serum lipids, whereas intergroup comparison showed a statistically significant reduction after treatment only in TC and LDL levels (P < 0.02 and <0.012). Conclusion: This study shows that fenugreek powder can be used adjunctive to SRP to control the glycemic status and serum lipid levels in uncontrolled NIDDM patients.